NEWS
3-4 December 2024
Leading European partnering event MedFIT welcomes sedivention, Lille (France)
sedivention connects with international key innovators in the MedTech, Diagnostic and Digital Health sectors from 30+ countries at the leading European partnering event MedFIT in Lille (France). We look forward to welcoming you at exhibition booth!
28 November 2024
Nordic Mentoring Network for Entrepreneurship (NOME) welcomes sedivention at the Open Startup Competition, Copenhagen (Danemark)
sedivention participates and presents at the Open Startup Competition at the Nordic Mentoring Network for Entrepreurship (NOME). NOME is an elite Nordic Mentoring program for promising life science projects and start-ups with world class mentors. NOME is funded by the Novo Nordisk Foundation.
18 November 2024
Financing is getting speed - High-Tech Gruenderfonds (HTGF) announces investment in sedivention
In a pre-seed financing round, sedivention secured substantial funding from High-Tech Gruenderfonds (HTGF). one of Europe's leading seed investors for high-tech start-ups.
HTGF is a venture capital investor for innovative technologies and business models. HTGF successfully supports the best founders whose ideas can revolutionise entire industries and improve people’s lives – from seed to exit.
That allows sedivention to advance product development and preclinical testing of the prototype which has already proven safe and effective.
November 2024
Ute Nollert, MD, founder of sedivention, joins the Deutsche Adipositas Gesellschaft, and as such becomes member of the European Association of the Study of Obesity (EASO), and the World Obesity Federation.
sedivention connects with national and international scientific organisations to broaden the scientific exchange. We are seeking feed-back to our innovative and unique therapy by presenting our approach at the conferences.
November 2024
sedivention becomes official member of the Startup-Verband (German Startup Association) (Germany)
With its membership at the Startup-Verband (German Startup Association) sedivention wants to advance the discussion on obesity therapies and is supported by the Startup -Verband in representing its interests in politics and business as well as in the general public.
October 2024
CDL (Creative Destruction Lab) accepts sedivention, Toronto (Canada), Berlin (Germany)
sedivention has been accepted to participate in the prestigious Creative Destruction Lab (CDL) program. CDL delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. CDL has its roots at the Rotman School of Management, which is part of the University of Toronto.
5-6 June 2024
sedivention at the health.tech conference in Munich (Germany)
sedivention takes part, showcases and meets investors at the health.tech conference in Munich, innovation & business for better healthcare.
19 September 2023
sedivention presents at Life Science Intelligence (LSI) Europe '23, Barcelona (Spain)
sedivention presents its innovative medical device and novel therapy during the LSI Europe '23 conference in Barcelona (Spain).
At the EMERGING MEDTECH SUMMIT 2023 taking place in Barcelona 18-22 September 2023, sedivention connected with the leading partners, innovators, investores, and strategics building medtech companies.
Presenting innovators like sedivention are an essential component of LSI Emerging Medtech Summits, showcasing the latest breakthroughs and developments in the medical technology sector.
28 August 2023
Bavarian start-up scene recognizes novel therapy for obesity from sedivention
sedivention and its novel therapy for obesity recognized in Bavarian the start-up scene.
26 July 2023
Second place for sedivention at BayStartUP Munich Business Plan Competition
sedivention took part in the third phase of the Munich Business Plan Competition and convinced the judges with its promising business concept.
Treatment of obesity by obliterating the "hunger nerve" from inside the stomach: sedivention is developing a cryo-catheter and a cryo-ballon, the "Blizzard Balloon", to treat obesity. The nerve fibers that transmit the feeling of hunger from the stomach to the brain are sclerosed from the stomach using cold - on an outpatient and non-invasive basis. The patient then no longer feels hungry and can lose weight more easily.
Press release BayStartUP (26 July 2023)
Press release Foerderbank Bayern (LfA) (27 July 2023)
Press release Bavarian Biotech Cluster Development (27 July 2023)
26 June 2023
Science4Life awards sedivention for its outstanding business idea
Development of a medical device for an one-off, outpatient treatment against obesity: similar to a gastroscopy, the nerves that transmit the feeling of hunger from the stomach to the brain are sclerosed. This reduces the feeling of hunger and makes it easier to lose weight. Without implants, surgery or medication.
11-12 June 2024
sedivention meets partners and investors at the HTGF Family Day 2024 in Berlin, Germany
sedivention will be present and meet investors at the High-tech Gruenderfonds (HTGF) Family Day in Berlin (GER), convention and conference.
The sedivention team will make connections with a diverse investor community, engage with visionary entrepreneurs, and interact with like-minded innovators!
24 May 2023
sedivention wins 1st place from BayStartUP - Munich Business Plan Competition
New medical device and innovative therapy convices jury.
sedivention has been awarded with the 1st place from BayStartUP for its development of a new medical device and innovative therapy.
The sedivention team took part in phase 2 of the Munich Business Plan Competition 2023 and impressed the judges with its promising business concept.
The therapy allows a minimally invasive, outpatient one-time treatment to freezing the "hunger nerve" and cuts down costs and miminizes complications of obesity therapy.
For sedivention as high-tech start-up in the medtech sector, the Munich Business Plan Competition offers fantastic opportunities to network with other start-ups and exchange experiences. The most important experience during the competition, is the constructive criticism the team received from the honorary judges, which helps the sedivention team to develop further the business idea and driving it to success.
14 March 2023
BayStartUP nominates sedivention to be one of the 10 most successfull start-ups
The Munich Business Plan Competition 2023 comes to its final phase and sedivention is nominated as one of the top 10 start-ups.
The jury was impressed by the innovative therapy and convinced that sedivention's business model and approach will be successful on the market.
© Sedivention GmbH 2024 - All rights reserved
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.